U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析

◆英語タイトル:U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH7499FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

U.S. Stem Cell Inc (USRM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company’s lead product MyoCell is an autologous muscle stem cell therapy for improving cardiac functions of a patient with serious, chronic heart damage due to heart attack. Its other lead product is MyoCell SDF-1, an improvement of MyoCell for similar applications; AdipoCell, a proprietary kit used for the isolation of adipose (fat) derived stem cells. The company provides laboratory services, regenerative medicine and cell therapy training services, and operates a cell therapy clinic. The company primarily operates in the US and sales its products to non-US countries as well. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc Key Recent Developments

Sep 30,2020: U.S. Stem Cell confirms date for appeals court oral arguments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
U.S. Stem Cell Inc – Key Facts
U.S. Stem Cell Inc – Key Employees
U.S. Stem Cell Inc – Key Employee Biographies
U.S. Stem Cell Inc – Major Products and Services
U.S. Stem Cell Inc – History
U.S. Stem Cell Inc – Company Statement
U.S. Stem Cell Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
U.S. Stem Cell Inc – Business Description
U.S. Stem Cell Inc – Corporate Strategy
U.S. Stem Cell Inc – SWOT Analysis
SWOT Analysis – Overview
U.S. Stem Cell Inc – Strengths
U.S. Stem Cell Inc – Weaknesses
U.S. Stem Cell Inc – Opportunities
U.S. Stem Cell Inc – Threats
U.S. Stem Cell Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
U.S. Stem Cell Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 30, 2020: U.S. Stem Cell confirms date for appeals court oral arguments
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
U.S. Stem Cell Inc, Key Facts
U.S. Stem Cell Inc, Key Employees
U.S. Stem Cell Inc, Key Employee Biographies
U.S. Stem Cell Inc, Major Products and Services
U.S. Stem Cell Inc, History
U.S. Stem Cell Inc, Joint Venture
U.S. Stem Cell Inc, Key Competitors
U.S. Stem Cell Inc, Ratios based on current share price
U.S. Stem Cell Inc, Annual Ratios
U.S. Stem Cell Inc, Annual Ratios (Cont...1)
U.S. Stem Cell Inc, Interim Ratios
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
U.S. Stem Cell Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UK Green Investment Bank Ltd:電力:M&Aディール及び事業提携情報
    Summary UK Green Investment Bank Ltd (UK Green) is an investment firm that offers green infrastructure investment services in the UK. The firm primarily invests on renewable energy and energy efficiency projects that include offshore wind, green deals and waste and bio energy and onshore renewable e …
  • Leukemia & Lymphoma Society Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, an …
  • VAALCO Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    VAALCO Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary VAALCO Energy, Inc. (VAALCO) is an upstream oil and gas company. It acquires, explores, develops and produces crude oil and natural gas from assets. The company conducts the exploration activities …
  • Synaffix BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Metorex Ltd:企業の戦略・SWOT・財務情報
    Metorex Ltd - Strategy, SWOT and Corporate Finance Report Summary Metorex Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Chimei Innolux Corporation (3481):企業の財務・戦略的SWOT分析
    Chimei Innolux Corporation (3481) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Chico’s FAS Inc:企業の戦略・SWOT・財務情報
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Anik Industries Ltd.:企業の戦略・SWOT・財務情報
    Anik Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anik Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • Capitol Health Ltd (CAJ):企業の財務・戦略的SWOT分析
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, mammography, nuclear medic …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NTN Corporation:企業の戦略・SWOT・財務情報
    NTN Corporation - Strategy, SWOT and Corporate Finance Report Summary NTN Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ACEA Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary ACEA Biosciences Inc (ACEA) is a biotechnology company that development and commercialization of cell analysis instruments for life science research and clinical diagnostics. The company's products include impedance-based, label-free, and real-time cell analysis systems, benchtop flow cytome …
  • Colfax Corporation (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • TearScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a si …
  • Ocean Capital Limited:企業の戦略・SWOT・財務分析
    Ocean Capital Limited - Strategy, SWOT and Corporate Finance Report Summary Ocean Capital Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆